The UCA1 and microRNA-18a signaling pathway mediates the irisin-lowering effect of metformin in the management of polycystic ovary syndrome

Introduction The present study aimed to clarify the underlying mechanism of metformin (met) in the management of polycystic ovary syndrome (PCOS) and to explore the role of UCA1/ microRNA-18a signaling pathway in the control of PCOS. Material and methods Real-time PCR was performed to compare the l...

Full description

Bibliographic Details
Main Authors: Wei Wang, Tian Hua, Xiaodong Li, Xinxian Zhang, Wei Hao
Format: Article
Language:English
Published: Termedia Publishing House 2021-03-01
Series:Archives of Medical Science
Subjects:
Online Access:https://www.archivesofmedicalscience.com/The-UCA1-and-microRNA-18a-signaling-pathway-mediates-the-irisin-lowering-effect-of,103379,0,2.html
_version_ 1797998106604732416
author Wei Wang
Tian Hua
Xiaodong Li
Xinxian Zhang
Wei Hao
author_facet Wei Wang
Tian Hua
Xiaodong Li
Xinxian Zhang
Wei Hao
author_sort Wei Wang
collection DOAJ
description Introduction The present study aimed to clarify the underlying mechanism of metformin (met) in the management of polycystic ovary syndrome (PCOS) and to explore the role of UCA1/ microRNA-18a signaling pathway in the control of PCOS. Material and methods Real-time PCR was performed to compare the level of irisin, blood glucose, UCA1 and miR-18a among PCOS, PCOS + Met, and control groups using area under curve (AUC) values. In-silicon analysis and luciferase assay were performed to explore the regulatory relationship among UCA1, miR-18a and irisin. Real-time PCR and Western-blot analysis were carried out to detect the effect of met on the expression of UCA1, miR-18a and irisin. Results AUC of UCA1 was the highest while AUC of irisin was the lowest. Also, irisin and UCA1 levels in the PCOS group were much higher than those in the PCOS + Met group, while miR-18a level in the PCOS group was much lower than PCOS + Met group. Through the luciferase assay, miR-18a was proved to directly bound to irisin 3’UTR. Additionally, irisin was identified to be a target gene of miR-18a. Finally, the treatment with met at the increasing concentration reduced the level of UCA1 and irisin but increased the level of miR-18a in a dose dependent manner. Conclusions In the management of PCOS, the irisin-lowering effect of met is regulated by the UCA1/miR-18a/RhoB signaling pathway.
first_indexed 2024-04-11T10:43:15Z
format Article
id doaj.art-5c19e12b878c485fb7500fc608090cd9
institution Directory Open Access Journal
issn 1734-1922
1896-9151
language English
last_indexed 2024-04-11T10:43:15Z
publishDate 2021-03-01
publisher Termedia Publishing House
record_format Article
series Archives of Medical Science
spelling doaj.art-5c19e12b878c485fb7500fc608090cd92022-12-22T04:29:08ZengTermedia Publishing HouseArchives of Medical Science1734-19221896-91512021-03-0118248949810.5114/aoms/103379103379The UCA1 and microRNA-18a signaling pathway mediates the irisin-lowering effect of metformin in the management of polycystic ovary syndromeWei Wang0Tian Hua1Xiaodong Li2Xinxian Zhang3Wei Hao4Department of Reproduction, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei Province, ChinaDepartment of Gynecology, Xingtai People’s Hospital Affiliated to Hebei Medial University, Xingtai, Hebei Province, ChinaDepartment of Gynecology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei Province, ChinaDepartment of Reproduction, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei Province, ChinaDepartment of Reproduction, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei Province, ChinaIntroduction The present study aimed to clarify the underlying mechanism of metformin (met) in the management of polycystic ovary syndrome (PCOS) and to explore the role of UCA1/ microRNA-18a signaling pathway in the control of PCOS. Material and methods Real-time PCR was performed to compare the level of irisin, blood glucose, UCA1 and miR-18a among PCOS, PCOS + Met, and control groups using area under curve (AUC) values. In-silicon analysis and luciferase assay were performed to explore the regulatory relationship among UCA1, miR-18a and irisin. Real-time PCR and Western-blot analysis were carried out to detect the effect of met on the expression of UCA1, miR-18a and irisin. Results AUC of UCA1 was the highest while AUC of irisin was the lowest. Also, irisin and UCA1 levels in the PCOS group were much higher than those in the PCOS + Met group, while miR-18a level in the PCOS group was much lower than PCOS + Met group. Through the luciferase assay, miR-18a was proved to directly bound to irisin 3’UTR. Additionally, irisin was identified to be a target gene of miR-18a. Finally, the treatment with met at the increasing concentration reduced the level of UCA1 and irisin but increased the level of miR-18a in a dose dependent manner. Conclusions In the management of PCOS, the irisin-lowering effect of met is regulated by the UCA1/miR-18a/RhoB signaling pathway.https://www.archivesofmedicalscience.com/The-UCA1-and-microRNA-18a-signaling-pathway-mediates-the-irisin-lowering-effect-of,103379,0,2.htmluca1mir-18airisinmetpolycystic ovary syndrome
spellingShingle Wei Wang
Tian Hua
Xiaodong Li
Xinxian Zhang
Wei Hao
The UCA1 and microRNA-18a signaling pathway mediates the irisin-lowering effect of metformin in the management of polycystic ovary syndrome
Archives of Medical Science
uca1
mir-18a
irisin
met
polycystic ovary syndrome
title The UCA1 and microRNA-18a signaling pathway mediates the irisin-lowering effect of metformin in the management of polycystic ovary syndrome
title_full The UCA1 and microRNA-18a signaling pathway mediates the irisin-lowering effect of metformin in the management of polycystic ovary syndrome
title_fullStr The UCA1 and microRNA-18a signaling pathway mediates the irisin-lowering effect of metformin in the management of polycystic ovary syndrome
title_full_unstemmed The UCA1 and microRNA-18a signaling pathway mediates the irisin-lowering effect of metformin in the management of polycystic ovary syndrome
title_short The UCA1 and microRNA-18a signaling pathway mediates the irisin-lowering effect of metformin in the management of polycystic ovary syndrome
title_sort uca1 and microrna 18a signaling pathway mediates the irisin lowering effect of metformin in the management of polycystic ovary syndrome
topic uca1
mir-18a
irisin
met
polycystic ovary syndrome
url https://www.archivesofmedicalscience.com/The-UCA1-and-microRNA-18a-signaling-pathway-mediates-the-irisin-lowering-effect-of,103379,0,2.html
work_keys_str_mv AT weiwang theuca1andmicrorna18asignalingpathwaymediatestheirisinloweringeffectofmetformininthemanagementofpolycysticovarysyndrome
AT tianhua theuca1andmicrorna18asignalingpathwaymediatestheirisinloweringeffectofmetformininthemanagementofpolycysticovarysyndrome
AT xiaodongli theuca1andmicrorna18asignalingpathwaymediatestheirisinloweringeffectofmetformininthemanagementofpolycysticovarysyndrome
AT xinxianzhang theuca1andmicrorna18asignalingpathwaymediatestheirisinloweringeffectofmetformininthemanagementofpolycysticovarysyndrome
AT weihao theuca1andmicrorna18asignalingpathwaymediatestheirisinloweringeffectofmetformininthemanagementofpolycysticovarysyndrome
AT weiwang uca1andmicrorna18asignalingpathwaymediatestheirisinloweringeffectofmetformininthemanagementofpolycysticovarysyndrome
AT tianhua uca1andmicrorna18asignalingpathwaymediatestheirisinloweringeffectofmetformininthemanagementofpolycysticovarysyndrome
AT xiaodongli uca1andmicrorna18asignalingpathwaymediatestheirisinloweringeffectofmetformininthemanagementofpolycysticovarysyndrome
AT xinxianzhang uca1andmicrorna18asignalingpathwaymediatestheirisinloweringeffectofmetformininthemanagementofpolycysticovarysyndrome
AT weihao uca1andmicrorna18asignalingpathwaymediatestheirisinloweringeffectofmetformininthemanagementofpolycysticovarysyndrome